Platelet mitochondrial function and endogenous coenzyme Q10 levels are reduced in patients after COVID-19.
Level 4 - case-series / case-control
Small observational case-control study comparing post-COVID patients to healthy controls
PubMed 34967652 · doi:10.4149/BLL_2022_002
What was done
The study assessed mitochondrial bioenergetics and oxidative stress markers in 10 patients after COVID-19 and 15 healthy individuals. Peripheral blood platelets were isolated to measure mitochondrial respiratory chain function and oxidative phosphorylation via high-resolution respirometry. Coenzyme Q10 (CoQ10) levels were measured using high-performance liquid chromatography, and plasma thiobarbituric acid reactive substances (TBARS) were evaluated as a marker of oxidative stress.
What was found
Platelet mitochondrial respiratory chain function, oxidative phosphorylation capacity, and endogenous CoQ10 concentrations were reported to be reduced in patients after COVID-19 compared to healthy controls. The abstract does not provide numerical values, confidence intervals, or statistical significance metrics for any outcome.
Why it matters
This study provides preliminary human evidence of potential mitochondrial impairment and CoQ10 depletion in platelets following SARS-CoV-2 infection, offering a potential bioenergetic mechanism for persistent post-viral symptoms.
Limits
The sample size is extremely small (10 patients and 15 controls). The abstract omits all numerical data, effect sizes, statistical test results, and details on patient infection severity or time elapsed since acute COVID-19. Measurements were restricted to peripheral platelets rather than primary affected tissues, and speculative therapeutic benefits of CoQ10 supplementation were not tested.
Cited by
- supports SARS-CoV-2 enters the mitochondria and depletes cellular energy, driving long-term fatigue.